No products in the cart.

Anti-MAP3K8 antibody

SKU Product Brand Unit Availability Price Quantity  
AB-06-2796
Anti-MAP3K8 antibody
Erpan Tech In stock

Specifications        

Product Cat#: AB-06-2796
Product type: Primary antibody
Antigen: MAP3K8
Immunogen: KLH conjugated synthetic peptide derived from human MAP3K8/TPL2 121-220/468
Species immunized: Rabbit
Isotype: IgG
Applications: Western Blot (1:500-1:1000)
Reactivity: Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Rabbit
Clonality (clone number): Polyclonal
Form: Liquid
Buffer: TBS (pH7.4), 1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1 mg/ml
Purity: Protein A affinity purified
Storage: Store at -20℃ for one year. Avoid repeated freeze/thaw cycles
Alternative names: c COT
Cancer Osaka thyroid oncogene
Cancer Osaka thyroid oncogene
CCOT
COT
COT proto oncogene serine/threonine protein kinase
EST
ESTF
Ewing sarcoma transformant
FLJ10486
M3K8_HUMAN
MAP3K 8
MAP3K8
Mitogen activated protein kinase kinase kinase 8
Mitogen-activated protein kinase kinase kinase 8
Proto oncogene cCot
Proto-oncogene c-Cot
Serine/threonine protein kinase cot
Serine/threonine-protein kinase cot
TPL 2
TPL-2
TPL2
Show More

Target information

Required for lipopolysaccharide (LPS)-induced, TLR4-mediated activation of the MAPK/ERK pathway in macrophages, thus being critical for production of the proinflammatory cytokine TNF-alpha (TNF) during immune responses. Involved in the regulation of T-helper cell differentiation and IFNG expression in T-cells. Involved in mediating host resistance to bacterial infection through negative regulation of type I interferon (IFN) production. In vitro, activates MAPK/ERK pathway in response to IL1 in an IRAK1-independent manner, leading to up-regulation of IL8 and CCL4. Transduces CD40 and TNFRSF1A signals that activate ERK in B-cells and macrophages, and thus may play a role in the regulation of immunoglobulin production. May also play a role in the transduction of TNF signals that activate JNK and NF-kappa-B in some cell types. In adipocytes, activates MAPK/ERK pathway in an IKBKB-dependent manner in response to IL1B and TNF, but not insulin, leading to induction of lipolysis. Plays a role in the cell cycle. Isoform 1 shows some transforming activity, although it is much weaker than that of the activated oncogenic variant.

Provider

Erpantech Laboratory

download

MSDS-AB-06-2796.pdf (177 downloads)